DiaSys Presents Comprehensive Clinical Chemistry and Immunoturbidimetry Solutions

Diasys is exhibiting at Hall 3, Stand D44 where it is highlighting more than three decades of experience supplying laboratories in over 140 countries.

DiaSys offers a broad range of more than 90 ready-to-use reagents covering routine chemistry, lipid testing, liver and kidney function, coagulation-related markers, inflammatory biomarkers and special immunoturbidimetric assays. Calibrators and controls complement the reagent portfolio, providing complete system solutions for laboratories that require traceable, quality-assured testing components.

Products being featured at MEDICA 2025 include the Procalcitonin FS assay for rapid sepsis diagnosis, now available for the DiaSys respons systems and the BioMajesty JCA-BM6010/C. Also highlighted is the Total Bile Acids 21 FS assay, suitable for determining total bile acids in human serum and stool, serving as a sensitive marker of liver function and the primary marker for intrahepatic cholestasis of pregnancy. DiaSys has further expanded its cardiovascular risk assessment portfolio with two new reagents, HDL-c direct FS and LDL-c direct FS, both homogeneous assays designed for direct measurement.

DiaSys is additionally emphasizing its instrumentation portfolio, engineered to integrate seamlessly with its reagents. The respons c-line analyzers, including the respons 240c, respons 420c, and respons 600c, offer efficient and reliable testing options for small to medium-sized laboratories. The company is also showcasing specialized systems such as the respons A1c, an easy-to-use analyzer that enables rapid and reliable HbA1c determination from capillary blood using boronate affinity chromatography. Also on display is the newly launched respons UDS100, a compact urine analyzer designed to deliver fast and precise results using a dedicated 12-parameter test strip that includes standard parameters along with ACR.

Related Links:
DiaSys Diagnostics Systems